1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Prugen 2.0?

Discussion in 'Dermatology' started by anonymous, May 2, 2019 at 8:11 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    So, how is everything over there at the new Pru?
     

  2. anonymous

    anonymous Guest

    What happened to version 1.0?
     
  3. anonymous

    anonymous Guest

    2.0? More like -1. PruGen got sold a bill of goods by Asembia. Lonergan is throwing money down the drain while Kriel sabotages the business. Lonergan is a dumb fuck for trusting that POS. WTF do Kriel & Baker do besides waste Lonergan's money? Sales Comp this quarter is SHIT. Rumor is they're selling GenRx to save money. Won't work. PruGen has 6-9 months before it all caves in.
     
  4. anonymous

    anonymous Guest

    $0 copay is not a sustainable model if branded meds are $0, full stop. The smart docs have moved on, you should too.
     
  5. anonymous

    anonymous Guest

    Thank you to whoever wrote the post about Kriehl and Baker. Same story with these two idiots for the past few years.

    Prugen is dead.
     
  6. anonymous

    anonymous Guest

    Lonergan is throwing money down the drain while Kriel sabotages the business. Lonergan is a dumb fuck for trusting that POS. WTF do Kriel & Baker do besides waste Lonergan's money?
     
  7. anonymous

    anonymous Guest

    $5 copay is a sustainable model if branded meds are $10, full stop. The dumb docs have moved on, you should too.
     
  8. anonymous

    anonymous Guest

    You're joking right? Kriel is the only thing keeping Lonergan from destroying the business. Lonergan is always chasing the next shiny thing. Kriel keeps him somewhat grounded in reality.
     
  9. anonymous

    anonymous Guest

    That's the truth. Asembia is crap.
     
  10. anonymous

    anonymous Guest

    Lonergan is a dummy for trusting that POS. WTF do Kriel & Baker do besides waste Lonergan's money? Sales Comp this quarter is SHIT. Rumor is they're selling GenRx to save money. Won't work. PruGen has 6-9 months before it all caves in.